See Investigational New Drug.
Glossary
IND
02.27.12
-
Breaking News | Drug Development | Industry News
Veklury Reduced Risk of Hospitalization in High-Risk COVID-19 Patients
Veklury demonstrated a statistically significant 87% reduction in risk for the composite primary endpoint of COVID-19 related hospitalization.
-
Breaking News | Clinical Trials
First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy
TAC01-HER2 was developed for the treatment of HER2-overexpressing cancers.
-
Breaking News | Industry News
Recro Acquires IRISYS to Expand CDMO Capabilities
From pre-IND development to commercial manufacturing and packaging for wide range of dosage forms.
-
Drug Development | Trials & Filings
AskBio’s Gene Therapy Gets Fast Track
LION-101 is a recombinant adeno-associated virus (rAAV) based vector being developed as a one-time treatment for Limb-Girdle Muscular Dystrophy.
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News
Novasep, Exelixis Ink ADC Manufacturing Agreement
Covers the cGMP clinical manufacturing of a next-generation ADC drug candidate.
